{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:44:21Z","timestamp":1759099461615},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ijcard.2005.03.028","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:49:22Z","timestamp":1115747362000},"page":"220-224","source":"Crossref","is-referenced-by-count":1,"title":["Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?"],"prefix":"10.1016","volume":"107","author":[{"given":"Giovanni","family":"Cioffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"De Feo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pulignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Del Sindaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Stefenelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Opasich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2005.03.028_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.287.7.883","article-title":"Beta-blocker therapy in heart failure","volume":"287","author":"Foody","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.03.028_bib2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.03.028_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.03.028_bib4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9343(02)01346-3","article-title":"The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11942 elderly patients with heart failure","volume":"113","author":"Sin","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-5273(02)00321-2","article-title":"Study of the effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with heart failure (SENIORS). Rationale and design","volume":"86","author":"Shibata","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.028_bib7","first-page":"VI102","article-title":"The influence of atrial fibrillation on prognosis in mild to moderate heart failure","volume":"87","author":"Carson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.028_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","article-title":"Randomized trial of low-dose amiodarone in severe congestive heart failure","volume":"334","author":"Doval","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.03.028_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Result of a Veterans Administration Cooperative Study (V-HeFT)","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"314","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.84.1.40","article-title":"Prognostic significance of atrial fibrillation in advanced heart failure","volume":"84","author":"Middlekauff","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.028_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2005.03.028_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham heart study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.028_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","article-title":"Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials","volume":"32","author":"Dries","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.028_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0735-1097(98)00221-6","article-title":"Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm","volume":"32","author":"Pozzoli","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.028_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mhj.2001.117318","article-title":"Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US carvedilol heart failure trials program","volume":"142","author":"Joglar","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2005.03.028_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1388-9842(02)00031-4","article-title":"Is beta-blockage useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials","volume":"4","author":"Fung","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2005.03.028_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/heart.89.3.293","article-title":"Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study","volume":"89","author":"Arnold","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2005.03.028_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1054\/jcaf.2001.22491","article-title":"Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis","volume":"7","author":"Schleman","year":"2001","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2005.03.028_bib22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.028_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1067\/mhj.2001.117600","article-title":"Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial","volume":"142","author":"Wedel","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2005.03.028_bib24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1053-2498(02)00459-X","article-title":"Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma","volume":"21","author":"Kotlyar","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2005.03.028_bib25","article-title":"Cardioselective beta-blockers for reversible airways disease","volume":"1","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2005.03.028_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/heart.84.6.615","article-title":"Baseline predictors of tolerability to carvedilol in patients with chronic heart failure","volume":"84","author":"Krum","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2005.03.028_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/heart.88.6.611","article-title":"Beta-blockers in older persons with heart failure: tolerability and impact on quality of life","volume":"88","author":"Baxter","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2005.03.028_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.289.6.712","article-title":"Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Effects of initiating carvedilol in patients with severe chronic heart failure results from the Copernicus study","volume":"289","author":"Krum","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.03.028_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/heart.89.3.299","article-title":"Beta blockers in patients with congestive heart failure: guided use in clinical practice investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the bring-up experience","volume":"89","author":"Maggioni","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2005.03.028_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0735-1097(98)00680-9","article-title":"Tolerability and efficacy of carvedilol in patients with New York heart association class IV heart failure","volume":"33","author":"Macdonald","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.028_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(00)02606-4","article-title":"Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction","volume":"356","author":"Rochon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.03.028_bib32","first-page":"166","article-title":"Prevalence, predictors and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >\u00a070 years of age with recently diagnosed systolic heart failure","volume":"vol. 92","year":"2003"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305005723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305005723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T08:37:24Z","timestamp":1550565444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527305005723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0167527305005723"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2005.03.028","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}